Those dam-aged telomeres!

Current Opinion in Genetics and Development

Volumn 14, Issue 1, 2004, Pages 22-28

  Harrington, Lea ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CHROMOSOME DAMAGE; CHROMOSOME LOSS; DISEASE MARKER; DNA DAMAGE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TELOMERE;

EID: 0842287637     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2003.12.007     Document Type: Review

References (83)

1. Hackett J.A., Greider C.W. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene. 21:2002;619-626.
2. Karlseder J. Telomere repeat binding factors: keeping the ends in check. Cancer Lett. 194:2003;189-197.
3. Greider C.W. Telomeres and senescence: the history, the experiment, the future. Curr. Biol. 8:1998;R178-R181.
4. Shay J.W., Pereira-Smith O.M., Wright W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell. Res. 196:1991;33-39.
5. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 16:1997;6018-6033.
6. Sandell L.L., Zakian V.A. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell. 75:1993;729-739.
7. Harrington L., Robinson M.O. Telomere dysfunction: multiple paths to the same end. Oncogene. 21:2002;592-597.
8. Greenberg R.A., Chin L., Femino A., Lee K.H., Gottlieb G.J., Singer R.H., Greider C.W., DePinho R.A. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 97:1999;515-525.
9. Gonzalez-Suarez E., Samper E., Flores J.M., Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26:2000;114-117.
10. Wong K.K., Master R.S., Bachoo R.M., Menon J., Carrasco D.R., Gu T., Alt F.W., DePinho R.A. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates aging. Nature. 421:2003;643-648 In an Atm-deficient genetic background, containing shortened telomeres, increased genome instability led to proliferative defects in several tissues and a decreased incidence of lymphomas. This study argues the case of critically short telomeres as a suppressor of neoplasia.
11. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:2000;641-645.
12. Farazi P.A., Glickman J., Jiang S., Yu A., Rudolph K.L., DePinho R.A. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res. 63:2003;5021-5027 Three cancer-prone murine liver model systems (urokinase plasminogen activator transgenics, carbon tetrachloride exposure and diethylnistrosamine treatment) showed a suppression in the incidence and progression of tumors in mTerc-deficient mice; however, an increased incidence of early neoplasias was observed upon histological examination. This study highlights the dual role of telomere instability in tumor initiation and progression.
13. Rudolph K.L., Millard M., Bosenberg M.W., DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28:2001;155-159.
14. Artandi S.E., DePinho R.A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10:2000;39-46.
15. Chang W., Dynek J.N., Smith S. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev. 17:2003;1328-1333.
16. Zhu X.D., Kuster B., Mann M., Petrini J.H., Lange T. Cell-cycle- regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25:2000;347-352.
17. Stansel R.M., Subramanian D., Griffith J.D. p53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem. 277:2002;11625-11628.
18. Stansel R.M., de Lange T., Griffith J.D. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20:2001;5532-5540.
19. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
20. Bailey S.M., Cornforth M.N., Kurimasa A., Chen D.J., Goodwin E.H. Strand-specific postreplicative processing of mammalian telomeres. Science. 293:2001;2462-2465.
21. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413.
22. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348.
23. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., de Lange T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12:2002;1635-1644 Several important facets of mammalian telomere-telomere fusions were examined here. Fusions accompanied degradation of the G-rich overhang, occurred within one cell cycle, occurred on both the leading and lagging strands between the G-strand of one and the C-strand of another, led to non-reciprocal translocations and were dependent on ligase IV.
24. Featherstone C., Jackson S.P. DNA double-strand break repair. Curr. Biol. 9:1999;R759-R761.
25. Doherty A.J., Jackson S.P. DNA repair: how Ku makes ends meet. Curr. Biol. 11:2001;R920-R924.
26. Bertuch A.A. Telomeres: the molecular events driving end-to-end fusions. Curr. Biol. 12:2002;R738-R740.
27. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:2003;1549-1556 Cytological examination of uncapped telomeres revealed foci (called telomere dysfunction-induced foci, or TIFs) that shared several hallmarks of other DNA damage inducible foci, in both protein composition and response to checkpoint activation. These data establish a physiological role of DNA damage pathways in responding to loss of telomere function.
28. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint-mediated response in telomere-initiated senescence. Nature. 426:2003;194-198 This study documents the appearance of DNA damage-inducible foci in senescent primary fibroblasts, and provides functional evidence that these foci contribute directly to the senescent phenotype. This study establishes the molecular and mechanistic similarities between critically shortened and uncapped telomeres, and that telomere attrition does induce a DNA damage response in primary human cells.
29. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 295:2002;2446-2449 Remarkably, TRF2 overexpression delays the onset of cell arrest in primary human fibroblasts, despite the fact that telomeres are shorter than those normally observed at cellular senescence. TRF2, thus, appears to actively suppress the DNA damage signal that might contribute to cell arrest via critically shortened telomeres.
30. Stewart S.A., Ben-Porath I., Carey V.J., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 33:2003;492-496.
31. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A.et al. Telomerase maintains telomere structure in normal human cells. Cell. 114:2003;241-253.
32. Cervantes R.B., Lundblad V. Mechanisms of chromosome-end protection. Curr. Opin. Cell. Biol. 14:2002;351-356.
33. Taggart A.K., Teng S.C., Zakian V.A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science. 297:2002;1023-1026.
34. Garvik B., Carson M., Hartwell L. Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol. Cell. Biol. 15:1995;6128-6138.
35. •• ]) and end-protection.
36. Lydall D. Hiding at the ends of yeast chromosomes: telomeres, nucleases and checkpoint pathways. J. Cell. Sci. 116:2003;4057-4065.
37. Jacob N.K., Kirk K.E., Price C.M. Generation of telomeric G strand overhangs involves both G and C strand cleavage. Mol. Cell. 11:2003;1021-1032 Using a powerful and informative assay, Jacob and colleagues demonstrate that end processing in ciliates occurs at both the G-strand and C-strand. Although telomerase depletion does not significantly alter this process, these data point to an active cleavage pathway for both strands of the telomere. Surprisingly, mutation of the telomerase RNA template, which changes the sequence of the telomere, does not significantly alter the position of cleavage.
38. Gravel S., Larrivee M., Labrecque P., Wellinger R.J. Yeast Ku as a regulator of chromosomal DNA end structure. Science. 280:1998;741-744.
39. Boulton S.J., Jackson S.P. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J. 17:1998;1819-1828.
40. Baumann P., Cech T.R. Protection of telomeres by the Ku protein in fission yeast. Mol. Biol. Cell. 11:2000;3265-3275.
41. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 292:2001;1171-1175.
42. Baumann P., Podell E., Cech T.R. Human pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell. Biol. 22:2002;8079-8087.
43. Lundblad V. Telomeres: taking the measure. Nature. 424:2003;926-927.
44. Loayza D., De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 424:2003;1013-1018 In cells with reduced G-strand overhangs, the intensity of POT1 at the telomere is reduced, suggesting that POT1 is dispersed along the length of the telomere, as well as the terminus. Moreover, a mutant form of POT1, that should disrupt its DNA binding activity, abrogates the ability of TRF1 to suppress telomere lengthening by telomerase. These data point to a negative role of POT1 in telomerase access to the telomere.
45. Colgin L.M., Baran K., Baumann P., Cech T.R., Reddel R.R. Human POT1 facilitates telomere elongation by telomerase. Curr. Biol. 13:2003;942-946 Overexpression of POT1 leads to telomere lengthening, in a telomerase-dependent manner. Although this study appears paradoxical to the previous reference, there are other examples of end-binding proteins that can have both positive and negative influences on the telomere.
46. Lundblad V. Telomere maintenance without telomerase. Oncogene. 21:2002;522-531.
47. Lundblad V., Szostak J.W. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell. 57:1989;633-643.
48. Nugent C.I., Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1998;1073-1085.
49. Evans S.K., Lundblad V. The Est1 subunit of Saccharomyces cerevisiae telomerase makes multiple contributions to telomere length maintenance. Genetics. 162:2002;1101-1115.
50. Evans S.K., Lundblad V. Est1 and Cdc13 as comediators of telomerase access. Science. 286:1999;117-120.
51. Cohn M., Blackburn E.H. Telomerase in yeast. Science. 269:1995;396-400.
52. Lingner J., Cech T.R., Hughes T.R., Lundblad V. Three ever shorter telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc. Natl. Acad. Sci. USA. 94:1997;11190-11195.
53. Singh S.M., Lue N.F. Ever shorter telomere 1 (EST1)-dependent reverse transcription by Candida telomerase in vitro: evidence in support of an activating function. Proc. Natl. Acad. Sci. USA. 100:2003;5718-5723 Intriguingly, est1Δ cell extracts in C. albicans display a defect in the elongation of certain telomeric DNA permutations in vitro. The basis for this defect is not yet understood but it does suggest that Est1 may play a role in telomerase elongation, directly or indirectly.
54. Singh S.M., Steinberg-Neifach O., Mian I.S., Lue N.F. Analysis of telomerase in Candida albicans: potential role in telomere end protection. Eukaryot Cell. 1:2002;967-977.
55. Beernink H.T., Miller K., Deshpande A., Bucher P., Cooper J.P. Telomere maintenance in fission yeast requires an est1 ortholog. Curr. Biol. 13:2003;575-580 Genetic and biochemical evidence support the identification of a new Est1 homolog in S. pombe. Interestingly, est1Δ taz1Δ cells showed a reduced viability in meiosis. Although the nature of this phenotype is not extensively explored, it suggests that est1Δ cells, unlike trt1Δ (telomere reverse transcriptase) cells, might possess a telomere defect that activates a meiotic DNA damage response.
56. •].
57. •]) reports the identification and characterization of 1-3 putative human homologs of Est1. In this manuscript, overexpression of one of these, hEST1A, leads to telomere-telomere fusions and a loss in cell viability. These data corroborate the suggestion that Est1 orthologs play a role in end-protection.
58. Bertuch A.A., Lundblad V. Which end: dissecting Ku's function at telomeres and double-strand breaks. Genes Dev. 17:2003;2347-2350.
59. Stellwagen A.E., Haimberger Z.W., Veatch J.R., Gottschling D.E. Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends. Genes Dev. 17:2003;2384-2395 This study defines a key role for Ku in recruiting telomerase to telomeres and broken chromosome ends. A mutation of Ku that affects its ability to bind the telomerase RNA, but not its role in NHEJ, leads to telomere shortening, and a reduced ability to heal broken chromosome ends, particularly those with no telomere homology. This data suggests that Ku is a bona fide telomerase-associated component that regulates its capacity for telomere elongation in vivo.
60. Peterson S.E., Stellwagen A.E., Diede S.J., Singer M.S., Haimberger Z.W., Johnson C.O., Tzoneva M., Gottschling D.E. The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku. Nat. Genet. 27:2001;64-67.
61. Gravel S., Wellinger R.J. Maintenance of double-stranded telomeric repeats as the critical determinant for cell viability in yeast cells lacking Ku. Mol. Cell. Biol. 22:2002;2182-2193.
62. Teo S.H., Jackson S.P. Telomerase subunit overexpression suppresses telomere-specific checkpoint activation in the yeast yku80 mutant. EMBO Rep. 2:2001;197-202.
63. Riha K., Shippen D.E. Telomere structure, function and maintenance in Arabidopsis. Chromosome Res. 11:2003;263-275.
64. d'Adda di Fagagna F., Hande M.P., Tong W.M., Roth D., Lansdorp P.M., Wang Z.Q., Jackson S.P. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11:2001;1192-1196.
65. Hsu H.L., Gilley D., Blackburn E.H., Chen D.J. Ku is associated with the telomere in mammals. Proc. Natl. Acad. Sci. USA. 96:1999;12454-12458.
66. Chai W., Ford L.P., Lenertz L., Wright W.E., Shay J.W. Human Ku70/80 associates physically with telomerase through interaction with hTERT. J. Biol. Chem. 227:2002;47242-47247.
67. Li G., Nelsen C., Hendrickson E.A. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. USA. 99:2002;832-837.
68. Samper E., Goytisolo F.A., Slijepcevic P., van Buul P.P., Blasco M.A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1:2000;244-252.
69. Espejel S., Franco S., Rodriguez-Perales S., Bouffler S.D., Cigudosa J.C., Blasco M.A. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21:2002;2207-2219.
70. Wei C., Skopp R., Takata M., Takeda S., Price C.M. Effects of double-strand break repair proteins on vertebrate telomere structure. Nucleic Acids Res. 30:2002;2862-2870.
71. Hackett J.A., Feldser D.M., Greider C.W. Telomere dysfunction increases mutation rate and genomic instability. Cell. 106:2001;275-286.
72. Nautiyal S., DeRisi J.L., Blackburn E.H. The genome-wide expression response to telomerase deletion in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 99:2002;9316-9321.
73. Hackett J., Greider C.W. End resection initiates genomic instability in the absence of telomerase. Mol. Biol. Cell. 23:2003;8450-8461 This study suggests ssDNA is the lesion at a critically short telomere that heralds the onset of genetic instability in budding yeast. In the absence of Est1 and Exo1 (or Rad1), ssDNA overhangs are reduced, and the incidence of chromosome end-loss returns to virtually background levels. One remaining puzzle is why double mutant strains still undergo senescence; this suggests that other factors might contribute to cell arrest in the absence of telomerase, or that EXO1 is partially genetically redundant, with other factors that contribute to telomere instability.
74. Chan S.W., Blackburn E.H. Telomerase and ATM/Tel1p protect telomeres from non-homologous end joining. Mol. Cell. 11:2003;1379-1387.
75. Liti G., Louis E.J. NEJ1 prevents NHEJ-dependent telomere fusions in yeast without telomerase. Mol. Cell. 11:2003;1373-1378.
76. Mieczkowski P.A., Mieczkowska J.O., Dominska M., Petes T.D. Genetic regulation of telomere-telomere fusions in the yeast Saccharomyces cerevisae. Proc. Natl. Acad. Sci. USA. 100:2003;10854-10859.
77. D'Mello N.P., Jazwinski S.M. Telomere length constancy during aging of Saccharomyces cerevisiae. J. Bacteriol. 173:1991;6709-6713.
78. McMurray M.A., Gottschling D.E. An age-induced switch to a hyper-recombinational state. Science. 301:2003;1908-1911 A careful analysis of LOH along a chromosome arm in diploid yeast reveals a dramatic rise in genetic instability as cells age. Molecular characterization of the LOH events reveals that 99% probably occur via a double-stranded DNA break, followed by breakage-induced replication. This study highlights the importance of studying subsets of cell populations, and suggests that a similar phenomenon might underlie the increased incidence of cancer in older humans.
79. Benard C., Hekimi S. Long-lived mutants, the rate of aging, telomeres and the germline in Caenorhabditis elegans. Mech. Ageing. Dev. 123:2002;869-880.
80. DePinho R.A. The age of cancer. Nature. 408:2000;248-254.
81. Vulliamy T.J., Knight S.W., Mason P.J., Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27:2001;353-357.
82. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 413:2001;432-435.
83. Comolli L.R., Smirnov I., Xu L., Blackburn E.H., James T.L. A molecular switch underlies a human telomerase disease. Proc. Natl. Acad. Sci. USA. 99:2002;16998-17003.